ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 34 filers reported holding ZOSANO PHARMA CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,159,000 | -43.0% | 5,148,907 | +18.9% | 0.00% | – |
| Q4 2021 | $2,035,000 | -34.6% | 4,330,635 | +0.2% | 0.00% | – |
| Q3 2021 | $3,111,000 | -22.6% | 4,322,161 | +2.2% | 0.00% | – |
| Q2 2021 | $4,017,000 | -15.5% | 4,227,922 | +10.3% | 0.00% | – |
| Q1 2021 | $4,752,000 | +154.5% | 3,832,063 | +8.2% | 0.00% | – |
| Q4 2020 | $1,867,000 | -63.8% | 3,542,848 | +11.2% | 0.00% | – |
| Q3 2020 | $5,159,000 | +331.4% | 3,184,750 | +128.0% | 0.00% | – |
| Q2 2020 | $1,196,000 | +56.3% | 1,396,756 | +2.7% | 0.00% | – |
| Q1 2020 | $765,000 | -47.1% | 1,359,999 | +43.0% | 0.00% | – |
| Q4 2019 | $1,446,000 | -2.6% | 951,051 | 0.0% | 0.00% | – |
| Q3 2019 | $1,484,000 | -52.6% | 951,051 | -0.6% | 0.00% | – |
| Q2 2019 | $3,129,000 | +49.9% | 957,025 | +118.6% | 0.00% | – |
| Q1 2019 | $2,088,000 | +448.0% | 437,720 | +143.7% | 0.00% | – |
| Q4 2018 | $381,000 | -82.7% | 179,592 | -66.6% | 0.00% | – |
| Q3 2018 | $2,201,000 | -3.0% | 538,154 | -3.2% | 0.00% | – |
| Q2 2018 | $2,268,000 | +21.0% | 555,840 | +49.5% | 0.00% | – |
| Q1 2018 | $1,874,000 | – | 371,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|